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Background: Sensorineural hearing impairment is a common pathological manifestation in patients affected by
X-linked intellectual disability. A few cases of interstitial deletions at Xq21 with several different phenotypic
characteristics have been described, but to date, a complete molecular characterization of the deletions harboring
disease-causing genes is still missing. Thus, the aim of this study is to realize a detailed clinical and molecular analysis
of a family affected by syndromic X-linked hearing loss with intellectual disability.
Results: Clinical analyses revealed a very complex phenotype that included inner ear malformations, vestibular
problems, choroideremia and hypotonia with a peculiar pattern of phenotypic variability. Genomic analysis revealed,
for the first time, the presence of two close interstitial deletions in the Xq21.1-21.3, harboring 11 protein coding, 9
non-coding genes and 19 pseudogenes. Among these, 3 protein coding genes have already been associated with
X-linked hearing loss, intellectual disability and choroideremia.
Conclusions: In this study we highlighted the presence of peculiar genotypic and phenotypic details in a family
affected by syndromic X-linked hearing loss with intellectual disability. We identified two, previously unreported,
Xq21.1-21.3 interstitial deletions. The two rearrangements, containing several genes, segregate with the clinical features,
suggesting their role in the pathogenicity. However, not all the observed phenotypic features can be clearly associated
with the known genes thus, further study is necessary to determine regions involved.
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Sensorineural hearing impairment (SNHI) can be con-
sidered the most frequent form of children’s hearing
loss (1/1000 born) and about 60% of the cases can be
ascribed to genetic causes [1]. Most of SNHI forms are
non-syndromic, representing 70% of all cases, even
though at least 400 known syndromes have been de-
scribed. Intellectual disability (ID) is a disorder that some-
times co-occurs with sensorineural hearing impairment.* Correspondence: franze@ceinge.unina.it
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unless otherwise stated.It represents one of the major handicaps affecting 1%
to 3% of the general population, with onset before age
18. It is more common in males because of the high
incidence of mutations in genes located on the X
chromosome [2]. To date, more than 80 chromosome
X-linked ID genes (XLID) have been identified [3]. In
most of them mutations give rise to syndromic ID forms,
often accompanied by behavioral, somatic, metabolic or
neurological disorders [4,5]. Syndromic forms can also
result from contiguous gene deletions. In particular, dele-
tions and rearrangements in the Xq21 have been linked
to other complex syndromes including ID, deafness,
choroideremia (CHM), seizures, and multiple congenital
anomalies [6-11]. Smaller deletions lead to a milderhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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few cases - in association with deafness and CHM [17,18].
In these cases, the patients carried interstitial deletions
within the Xq21. Schwartz et al. [19] mapped the deletion
identified by Rosenberg and collaborators [18] at the
Xq21.2-Xq21.31. More recently, a new 16 Mb deletion in
the same region has been described [20]. Nonetheless, a
complete molecular characterization of such deletions at
the Xq21, harboring disease-causing genes, is still missing.
In this study, we describe for the first time - to the best of
our knowledge - a systematic clinical, genomic and mo-
lecular analysis of a family with a complex phenotype
including syndromic congenital sensorineural X-linked
hearing loss. Our analysis revealed the presence of two
close interstitial deletions in the Xq21.1-21.3, harboring
several protein-coding genes. We also discuss the poten-
tial role of the deletions in the described phenotype.
This paper is dedicated to the memory of the Pediatrician
Dr. Alfredo Pisacane (1951–2012).Figure 1 Pedigree of the affected Italian family. Squares and
circles symbolize males and females, respectively. Unblackened and
blackened symbols denote unaffected and affected individuals,
respectively. Circles with a dot inside denote carrier females. Diagonal
lines denote deceased individuals. The arrow denotes the proband.Case presentation
A four-generation Italian family (Figure 1) with an X-
linked syndromic form of hearing impairment was
studied. The proband (IV-1) and his brother (IV-2)
had congenital bilateral hearing SNHL that had been
assessed by our group a few months after birth as de-
scribed in Chinetti et al. [21]. At 2 years of age both
individuals showed psycho-neuro-motor disabilities too,
with different degrees of severity. In the course of this
study, several other clinical signs, summarized in Table 1,
were observed. In detail: proband (IV-1) born in 2006, was
diagnosed with bilateral severe hearing SNHL at 5 months
of age. At 2 years of age, he was diagnosed with psycho-
neuro-motor disability. He presented also trunk and limb
hypotonicity, poor motor coordination, and was unable to
walk unsupported. He was fitted with hearing aids by
6 months of age, but since January 2012 has refused to
use them. At present, the ID is profound with no evolutive
process. Comprehension is very poor; he recognizes only
the use and function of simple and familiar objects. Verbal
language is absent and he use a mimic sign language with
motor stereotypies. He presents a psychotic behavioral
and relational disorder. He presents balance problems and
flat feet too. Proband’s brother (IV-2) born in 2007, was
diagnosed at 5 months with a SNHL similar to the pro-
band. Subsequently, at about 2 years of age, he was also
diagnosed with trunk and limbs hypotonicity and psycho-
neuro-motor disability. At present, he presents a pheno-
type similar to that of his brother but in a much milder
form. Like his brother, he recognizes only the use and
function of simple and familiar objects. Verbal language
and comprehension, in spite of constant hearing aid use,
is poor, but better than that of his elder brother.Subject III-1: Born in 1969; he was diagnosed in in-
fancy with bilateral profound SNHL and psycho-neuro-
motor disability. The intellectual disability is of medium
severity: he is sufficiently able to perform activities of
daily living on his own. Neuropsychological tests deter-
mined a deficit that primarily occurs in short term mem-
ory for spatial material. He had been fitted with hearing
aids for language development at nine years of age, and
presents a simple concrete verbal language with a good
verbal comprehension. Also this subject presents balance
problems and flat feet but motor stereotypies are absent.
Subject II-2: Born in 1947; he was diagnosed with pro-
found bilateral hearing loss and very severe developmen-
tal delay and intellectual disability. He was not able to
perform his activities of daily living unaided. Detailed
clinical examinations had never been performed.
The evaluation of patients by computed tomography
(CT) and magnetic resonance imaging (MRI) showed
significant alterations of the inner ear apparatus, with
some marked differences among affected individuals.
Table 1 Clinical details for affected subjects
IV-1 IV-2 III-1 II-2
Age (years) 8 7 35 -
- SNHL Congenital/Severe Congenital/Severe Congenital/Profound Congenital/
Profound
- Tympanometry Normal Normal Normal Normal
- Vestibular problems N.D. N.D. Mixed sufferance:
central and peripheral
N.D.
- ID Very Severe Severe Moderate Severe
- Age of hearing aids
fitting
6 months 6 months 9 years N.D.
- Constant use of hearing
aids
No Yes Yes N.D.
- Comprehension Very poor: recognition only of the use
and function of simple and familiar objects.
Psychotic behavioral and relational disorder
Poor: recognition only of
the use and function of
simple and familiar objects
Good N.D.
- Verbal language Absent: use of a mimic sign language Poor Concrete and fluent N.D.
- Trunk and limbs
hypotonicity
Present Present, but milder than
IV:1
Absent N.D.
- Motor stereotypies Present Present Absent N.D.
- CHM evaluation N.D. N.D. Alteration typical of
choroideremia
N.D.
- Brain MRI/CT Normal Normal Mega cisterna ampia.
Cerebral cysticercosis
N.D.
- Ear MRI/CT Inner ear strongly altered.
Small oval window
Inner ear strongly altered.
Small oval window
Inner ear strongly altered.
Dysplastic fine irregularity of
the profile of the semicircular
canals
N.D.
- Large forehead, down
turned rimae palpebrarum
and large ears
Present Present Not prominent N.D.
- Flat feet Present Present Present N.D.
N.D.: not disposable.
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III-1 individual revealed a bulbous dilatation of the in-
ternal auditory canals (IAC), associated with the absence
of the fundi of the bony plates separating the basal turn
of cochlea and IAC. The modiolus was completely ab-
sent and the cochlea was dysmorphic and small, espe-
cially the medium and the apical turn. A mild dilatation
of the vestibule and of the posterior semicircular canals
was present in both the siblings, and proband (IV-1) also
had a dilatation of the right vestibular aqueduct. In the
two children, CT also revealed a small oval window that
was not clearly appreciable in the individual III-1. Coch-
lear nerves were normal. The MRI analysis in the III-1
individual also showed a dysplastic fine irregularity in
the profile of the semicircular canals, not appreciable in
the other patients. Brain MRI of the subject III-1 revealed
the presence of a mega cisterna magna and cerebral cys-
ticercosis, while it did not reveal any morphological
malformation in the other two patients (IV-1, IV-2)
(Table 1). Figure 2 (panel 1, 2) reports MRI and CT of
subject IV-1. Due to the inability to communicate andpoor cooperation, it was possible to perform vestibular
analysis only on individual III-1. The presence of alter-
ations found in this subject suggest both central and per-
ipheral suffering. Indeed, for this subject, the presence of
a down nystagmus was shown in all positions, which was
found to be persistent, symmetric and partially inhibited
by visual fixation. Vestibulo-ocular reflex (VOR) was
hypoactive bilaterally and slightly reduced by visual fix-
ation. Finally, affected subjects presented some peculiar
facial characteristics too: large forehead, down turned
rimae palpebrarum and large ears.
No unaffected individuals or carrier females had men-
tal, auditory or other significant problems related to those
described in the affected individuals.
Results
Clinical characteristics of the affected individuals are re-
ported in Table 1. No abnormalities were indicated by pre-
vious high-resolution karyotype and fragile X molecular
analyses. Thus, we first decided to perform a mutational
screening in Gap junction beta-2 (GJB2), Gap junction
Figure 2 Images for subject IV-1: 1) Axial MR TSE drive T2-weighted image. Note the small bulbous dilatation of the lateral part of the IAC,
with absence of the modiolus and of the bone at the fundus. The cochlea is dysmorphic and small in size. The vestibule is dilated bilaterally.
Note also the dilatation of the vestibular acqueduct on the right side. 2) Axial CT. The absence of the bone fundi of IAC and of the modiolus are
better depicted on CT. Ophthalmic results: 3) Male patient affected with choroideremia. Color fundus images (a, right eye; b, left eye) and cross
sectional OCT B-scan (c, right eye; d, left eye) show diffuse atrophy of the retinal pigment epithelium and choriocapillaries and round retinal
pigment changes at the posterior pole and midperiphery. Ganglion cell complex thickness shows a severe arciform thinning in (e) the right eye,
while focal alterations are present in (f) the left eye. Retinal nerve fiber layer is reduced in the inferior quadrants in (g) the right and (h) left eye.
4) Female patient carrier of the choroideremia gene. Color fundus images (a, right eye; b, left eye), cross sectional OCT B-scan (c, right eye; d, left
eye), ganglion cell complex thickness map (e, right eye; f, left eye) and microperimetry (g, right eye; h, left eye) are normal. A choroidal nevus is
visible at the posterior pole in the left eye.
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ibosyl pyrophosphate synthetase 1 (PRPS1) and Gap junc-
tion beta-1 (GJB1). These analyses did not reveal the
presence of any mutation. Then, we carried out a linkage
analysis on this family. Unfortunately, significant results
were not obtained, possibly due to the presence of a large
deleted region and the consequent absence of specific
markers in that region. Finally, we used a genome-wide
approach, i.e. single nucleotide polymorphisms (SNPs)
array analysis. Using this approach we were able to
observe the presence of a deletion on X chromosome of
about 5.2 Mb, spanning from the Xq21.1 to Xq21.31,
from the nucleotide 81492309 to 86697958 (Figure 3A).
Regarding protein-coding genes only, in silico analysisrevealed that the deletion extends from POU class 3
homeobox 4 (POU3F4) to dachshund family transcrip-
tion factor 2 (DACH2) genes (Figure 3C). Information
about the coding genes mapping in the deleted region is
reported in Additional file 1: Table S1_1 (see Supplemen-
tary data online S1.doc, section 1). Region-specific poly-
merase chain reaction (PCR) analyses on genomic DNA
isolated from affected (III-1, IV-1, IV-2) and healthy
carrier (III-2) individuals confirmed the absence of all
these genes, and the presence of SH3 domain binding
glutamate-rich protein like (SH3BGRL) and kelch-like
family member 4 (KLHL4) genes mapping proximally
to the deletion. Then, to better refine the boundaries
of the deleted region we used comparative genomic
Figure 3 Info on deleted region. A) Graph of the marker-specific fluorescence (logR) and allele-specific fluorescence of SNPs on chromosome X in
1 of the patients. The deleted region is marked in dark pink. B) A-CGH profile of chromosome from the Agilent 1x1M array in the subject IV-2 shown
that the deletion of 5,77 Mbp includes a small undeleted region of about 40 Kb. C) SNPs array results: deleted genes are reported in the light grey
zone and undeleted genes in the dark grey zone. D) CGH array result: zones deleted are represented as dotted arrows. E) Refinement of breakpoint
deletions results by PCR analysis. Gridded zone represents regions that remained undetermined. F) Schematic representation of different classes of
genes identified in silico in the deleted region.The scale bar in the panel F refers to the entire genomic region that is deleted, whereas single genes
or transcripts are not in scale. However, the genomic localization of each gene in this region is respected.
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firmed the presence of a deletion of about 5.77 Mb, (chrX.
hg19:g.(80,916,762_80,955,540)_(86,709,812_86,736,428)del).
Interestingly, we also discovered that inside the deleted re-
gion in the proband (chrX.hg19:g.(80,916,762_80,937,379)_
(86,709,812_86,716,390)del.), a specific genomic region
from the nucleotide 86,506,732 to 86,547,605 was not de-
leted (Figure 3B). This analysis indicated the presence of
two close interstitial deletions, named “Del I” (of about
5.57 Mb) and “Del II” (of about 162 Kb). These two dele-
tions are spaced out by a region of about 41 Kb (Figure 3D).
The presence of this region was confirmed by PCR assays
(supplementary data online S1.doc, section 2: primers
DelF2/DelR2 in Additional file 1: Table S1_2) carried out in
all of the affected individuals (data not shown). Starting
from these results, a PCR-based assay was used to furtherrefine the two deletions’ breakpoints. Given the high con-
tent of repeated regions encompassing the deleted portion
of X chromosome, the exact sequence of some genomic
regions (indicated in Figure 3E as 1u-4u) is still undeter-
mined. However, these analyses allowed us to determine
that Del I consists of 5.56 Mb (with an ambiguity of about
25 Kb as shown in Figure 3E, 1u + 2u) and Del II consists
of 185.5 Kb (with an ambiguity of about 4 Kb, 3u + 4u).
Browsing the main public genomic databases, we observed
that the deleted region Del I contains several coding and
non-coding genes (Figure 3F). In particular, the in silico
analysis revealed that the patients carrying Del I completely
lack the genomic region encompassing 11 protein-coding, 9
non-coding genes and 19 pseudogenes. Within this region,
3 protein-coding genes (CHM, Pou3F4 and ZNF711) have
already been associated with syndromic congenital
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The other deleted genes are not associated with the ob-
served phenotypes, indicating them as potential contribu-
tors to the complex phenotype of affected individuals. No
genes are annotated in the 41 Kb region or in Del II. By re-
verse transcriptase PCR (RT-PCR) on RNA isolated from
peripheral blood mononuclear cells (PBMCs), we experi-
mentally confirmed that in the III-1 individual Del I and
Del II do not alter the expression of the two genes located
in close proximity of the 5′ and 3′ boundaries of the identi-
fied deletions: SH3BGRL and KLHL4 (Supplementary data
online Additional file 2: Figure S1).
Prior to this study, no significant visual disturbance had
been noticed in any of the family subjects. Therefore, as
also the CHM gene - involved in choroideremia onset -
was deleted, we carried out a detailed ophthalmological
study on individuals III-1 and III-2. Clinical alterations
typical of a CHM affected individual were observed for
patient III-1 (Figure 2, panel 3), whereas a mild phenotype,
typical of carrier individuals was reported in patient III-2
(Figure 2, panel 4).
Discussion
Sensorineural congenital hearing loss, vestibular problems,
intellectual disability, choroideremia, hypotonia and some
peculiar facial dysmorphisms have been observed in the
family members (Table 1). Few studies have reported some
of the phenotypic characteristics (intellectual disability,
hearing loss and choroideremia) here described [17,20].
However, a comprehensive clinical, genomic and molecu-
lar characterization has not yet been performed. It is par-
ticularly relevant to observe the phenotypic variability in
the family subjects reported in this study. In particular, the
large difference in the degree of intellectual disability,
which is more pronounced for proband (IV-1) compared
to his brother (IV-2) and above all to their uncle (III-1).
Indeed, even though individual III-1 did not undergo any
treatment during his infancy he had a very milder pheno-
type compared to his relatives. Some differences among
affected subjects have also been observed in the conform-
ation of the inner ear and brain (Table 1).
From a molecular point of view this is the first report of
two close deletions in the Xq21.1-21.3 regions: Del I and
Del II (Figure 3D). This genomic region encompasses sev-
eral genes, reported in detail in Figure 3C and Additional
file 1: Table S1_1 (see Supplementary data online S1.doc,
section 1). Three of them - POU3F4, ZNF711 and CHM -
are particularly significant for the clinical symptoms de-
scribed in the affected individuals. POU3F4 has a proven
role in hearing loss and inner ear malformations [22],
ZNF711 has been associated with simple ID [23] and
CHM with the choroideremia [24]. In the analyzed family,
choroideremia symptoms are not particularly significant.
Indeed, CHM has not been previously diagnosed in familymembers. CHM alterations have been determined only by
instrumental ophthalmic exams (Table 1; Figure 2, panel 3
and 4). Our study also documented other peculiar pheno-
typic features, such as hypotonia and facial dysmorphism,
in the family members. Interestingly, none of the genes
present in the deletion described is clearly associated with
these symptoms, as shown in Additional file 1: Table S1_1
(see Supplementary data online S1.doc, section 1).
However, although the other genes have not been as-
sociated with any of the observed pathological traits, we
cannot exclude that the encoded proteins may interact
with known disease-causing genes. Interestingly, brows-
ing BioGRID - an online interaction repository - we ob-
served that the protein encoded by RPS6KA6 gene has
more than 35 interactors, with a significant involvement
in “central nervous system development” and “negative
regulation of mesoderm development”. This observation
suggests that some deleted genes may potentially encode
proteins that interact, both directly and indirectly, with
other proteins whose function is strictly correlated with
the observed phenotypes. Other protein coding genes,
not mapping to the deleted X chromosome region, may
account for the unexpected pathological features. It indi-
cates that further genome-wide analyses are needed to
identify them. Moreover, our results highlight the pres-
ence of pseudogenes and of other non-coding genes in the
deleted region. Notably, both pseudogenes and ncRNAs
have been implicated in a novel regulatory networking
(acting as ceRNA) and have been recently been indicated
as relevant in neural cell plasticity and in neurodegen-
erative processes [25-28]. Therefore, we cannot exclude
that the deletion of some processed pseudogenes, long
ncRNAs (lncRNAs) and microRNAs (miRNAs) (Figure 3,
panel F), may affect the expression of other genes, located
elsewhere in the genome. Large-scale gene expression
studies in these patients (by RNA-Sequencing) will clarify
this crucial point. Del II deletion does not contain regula-
tory or coding sequences. This region may harbor a non-
pathogenic copy number variation (CNV), which may
have existed before the larger deletion arose. However,
browsing of public CNV databases [29] excluded the pres-
ence of rearrangements encompassing the small deletions.
However, the presence of still uncharacterized regions -
with relevant coding or regulatory functions - in Del II
cannot be excluded.
Conclusions
In this study we identified two, previously unreported,
Xq21.1-21.3 interstitial deletions in a family with a syn-
dromic form of hearing loss with variable phenotype.
The two rearrangements, segregate with the clinical fea-
tures in affected subjects, suggesting their role in the
pathogenicity. Not all the observed phenotypic features
can be clearly associated to known genes. The presence
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deleted region may correlate to the variable phenotype
observed, and potentially affect unexplored molecular
pathways or involve yet underestimated epigenetic mecha-
nisms. So, further studies are necessary to obtain a more
detailed genotype-phenotype correlation.
Data herein described confirm that this region of the
X chromosome is characterized by increased proneness
to chromosome breakage.
Methods
Affected individuals IV-1, IV-2 and III-1 were analyzed by
CT scan of ears and brain without contrast medium and
by MRI of brain and ears (Philips 1.5 T). Gadolinium in-
jection was subsequently required because of a suspected
associated brain cysticercosis in individual III-1. Vestibular
examination was performed with videonystagmoscopy
(VNS) and included testing for spontaneous and pos-
itional nystagmus (head-hanging, left and right lateral su-
pine positions) with and without visual fixation; testing for
VOR generated by passive head rotation in the horizontal
plane; VOR suppression test. Ophthalmic examination in-
cluded best-corrected visual acuity (BCVA) by Snellen
chart, intraocular pressure tonometry, anterior segment
examination and ophthalmoscopy. Combined spectral do-
main optical coherence tomography/microperimetry sys-
tem (SD-OCT, OCT/SLO, OPKO-OTI, Miami, FL) was
used to obtain fundus-related microperimetry [30,31]. For
fundus-related microperimetry, we used the Polar 3 test-
ing pattern, a stimulus size Goldmann III test spot (Ø = 26
arc/min), stimulus intensity between 16 and 0 dB (10–400
asb). The RTVue-100 SD-OCT device (Optovue, Inc., Fre-
mont, CA, USA) was used to obtain cross sectional B-
scans of the posterior pole, retinal thickness in the 3 mm
diameter central ring of the ETDRS map (central macular
thickness, CMT), thickness of the retinal ganglion cell
complex (GCC) and retinal nerve fiber layer (RNFL).
RTVue-100 incorporates a GCC scan mode to measure
inner macular retinal layer thickness, consisting of retinal
nerve fiber layer, ganglion cell layer and inner plexiform
layer, centered on the fovea and covering the central mac-
ula. For the peripapillary RNFL measurements, the RNFL
exam protocol was used for scan acquisition, which was
measured automatically at a diameter of 3.45 mm around
the center of the optic nerve. For mutational screening
genomic DNA was extracted by conventional salt pre-
cipitation protocols from peripheral blood samples col-
lected in EDTA-containing tubes or from buccal swabs
(Gentra System, DNA Isolation Kit). Amplified PCR frag-
ments of the exon 1 and 2 of the GJB2 gene were directly
sequenced as reported elsewhere [32]. The two hearing
loss-related deletions of the GJB6 gene, del (GJB6-
D13S1830) and del (GJB6-D13S1854), were screened
using a combined detection procedure [33]. For Charcout-Marie-Tooth genes (PRPS1, GJB1) see Supplementary data
online S1.doc, section 3). SNPs analysis was performed on
the genomic DNA isolated from the patient and his rela-
tives. All samples were genotyped using the Illumina
HumanCytoSNP-12 BeadChip using the standard proto-
col. All samples were then checked for mendelian errors
using Pedcheck and Pedstat [34]. Linkage analysis was
performed using an X-linked parametric model with minx
and complete penetrance [35]. High resolution a-CGH
analysis was performed on the genomic DNA of the pa-
tient and his relatives. DNA digestion, labeling and
hybridization were performed according to the manufac-
turer’s protocols. DNA specimens were analyzed with the
Human Genome CGH Microarray kit 4x180K (Agilent
Technologies, Santa Clara, CA), with an average space of
13 Kb and allowing an average resolution of 25 Kb. The
proband’s genomic DNA was further analyzed with the
Human Genome CGH Microarray kit 1xM (Agilent Tech-
nologies, Santa Clara, CA), with an average space of 2,1
Kb. Microarrays were scanned on the Agilent G2565CA
scanner and image files were quantified using Agilent’s
Feature Extraction software (V10.10.1.1); data were visual-
ized with Agilent’s Genomic Work Bench Standard Edi-
tion (V6.5.0.58). Primer pairs for PCR analyses were
designed using the Primer3 software [36]. The primer
pairs obtained were checked for non-specific hybridiza-
tions in other genome regions using the National Center
for Biotechnology Information (NCBI) Basic Local Align-
ment Search Tool (BLAST) [37]. The different amplified
fragments have a variable length due to the need to not
amplify regions of the X chromosome frequently repeated
in the entire genome, in particular, given the high pres-
ence of repeated sequences dispersed in the genomic re-
gion analyzed, we took advantage of the RepeatMask track
of the USCS Genome Browser [38] to design oligonucleo-
tide pairs to validate the deletions. Primer sequences and
PCR conditions used in this study are reported in supple-
mentary data online S1.doc, section 2). Total RNA was
isolated from PBMCs. PBMCs were separated by Ficoll
gradient centrifugation, placed in Trizol (Invitrogen), and
stored at −80°C according to the manufacturer’s. RNA in-
tegrity and concentration were evaluated by using the
Nanodrop (Thermo Scientific). The quality of RNA from
each sample was considered good if the 260/280 ratio was
in between 1.8 and 2.0.
RT-PCR reaction was carried out by reverse transcrip-
tion of total RNA using High Capacity cDNA Reverse
Transcription Kit (Life Technologies). Primer sequences
and PCR conditions on cDNA are reported in supplemen-
tary data online S1.doc, section 4). An extensive search for
the presence of transcripts mapping within the genomic
region encompassing the deletions has been performed
retrieving the main genomic databases. Gene annotation
tracks of RefSeq (release 62), Ensembl (version 74) and
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USCS Genome Browser [38]. All the transcripts, gener-
ated by alternative splicing, of protein coding and non-
coding genes have been considered for the analysis. Only
for genes proximal to the breakpoint, peaks of ChIP-Seq
data for transcription factors (TFs) binding (GENCODE)
were analyzed. The presence of binding sites for specific
transcription factors was evaluated by visual inspection of
ChIP-Seq tracks on Genome Browser.
The expression patterns, for both the protein and -
where available - the transcript, were evaluated by using
The Human Protein Atlas database [39].
This research was approved by the Ethics Committee of
University of Naples “Federico II” and written informed
consent for participation in the study was obtained from
all participants and from the parents of patients under 18
years of age before blood/saliva sampling.
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